Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clene Inc. - Common Stock (NQ: CLNN )

5.280 -0.610 (-10.36%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clene Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope
People suffering from incurable neurological diseases such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) hope new therapies and drugs will arrive sooner than later.    
Via Benzinga
Why Vicinity Motor Is Trading Higher By Over 65%; Here Are 26 Stocks Moving Premarket
Gainers Vicinity Motor Corp. (NASDAQ: VEV) rose 65.4% to $1.72 in pre-market trading. Vicinity Motor started deliveries of the first Class 3 electric truck to roll off the assembly line in Canada. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 44 companies hit new 52-week lows. 
Via Benzinga
Recap: Clene Q2 Earnings
  Clene (NASDAQ:CLNN) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Clene Shares Fall Despite Multiple Sclerosis Candidate Showing Neurological Improvements
Via Benzinga
HC Wainwright Initiates Coverage On This Nanocrystals Stock
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 127 companies set new 52-week lows. 
Via Benzinga
Domino's Pizza To $385? Plus This Analyst Cuts Price Target On Adaptimmune Therapeutics By Around 79%
UBS cut the price target on Domino's Pizza, Inc. (NYSE: DPZ) from $430 to $385. Domino's shares rose 4% to $329.11 on Tuesday. 
Via Benzinga
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per... 
Via Benzinga
Nasdaq Jumps 270 Points; Silver Surges Over 8%
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session
Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share. 
Via Benzinga
S&P 500 Surges 2%; Crude Oil Rises Sharply
U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600 points on Monday. 
Via Benzinga
US Stocks Open Higher; Dow Jumps 250 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 250 points on Monday. 
Via Benzinga
Why Clene Shares Are Trading Sharply Lower Monday
Clene Inc. (NASDAQ: CLNN) shares are trading lower by 25.90% to $2.09 during Monday's pre-market session after the company announced topline results in the Healey ALS Platform trial of CNM-Au8. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million. 
Via Benzinga
Clene Stock Falls As Lead Asset Fails To Show Survival, Function Benefit In Amyotrophic Lateral Sclerosis Trial
Via Benzinga
Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial
From Clene Inc.
Via GlobeNewswire
Clene to Report HEALEY ALS Platform Trial Topline Results on Monday, October 3
Conference Call and Webcast Set for 8:30 a.m. EDT 
From Clene Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million. 
Via Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Good morning, investors! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday! 
Via InvestorPlace
Why Is Turquoise Hill Resources Down By 18%: Here Are 31 Stocks Moving Premarket
Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 31.2% to $0.6931 in pre-market trading as the company presented positive data from ongoing ReSPECT™ clinical trials at the Annual Conference... 
Via Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
Gainers 
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness... 
Via Benzinga
Why Is Pinterest Higher By 14%? 20 Stocks Moving In Friday's Pre-Market Session
Gainers United Maritime Corporation (NASDAQ: USEA) rose 55% to $3.41 in pre-market trading. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on... 
Via Benzinga
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Nasdaq Turns Positive; Morgan Stanley Posts Weak Q2 Earnings
U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite turning higher on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
  
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.